Literature DB >> 21676553

Esthesioneuroblastoma: is there a need for elective neck treatment?

Candan Demiroz1, Orit Gutfeld, Mohamed Aboziada, Doris Brown, Lawrence J Marentette, Avraham Eisbruch.   

Abstract

PURPOSE: To assess the risk of cervical lymph node metastases after definitive treatment for esthesioneuroblastoma (ENB) that did not include elective neck therapy. METHODS AND MATERIALS: This was a retrospective analysis of 26 ENB patients treated at the University of Michigan between 1995 and 2007. Tumor stage was Kadish A in 1 patient, B in 19, C in 5, and unknown in 1. Craniofacial or subcranial resection was performed in 24 patients (92%), with negative margins in 22 (92%). Postoperative radiotherapy (RT) to the primary site was given in 12 patients (46%), and 14 patients (54%) had surgery alone. All patients had clinically N0 disease, and no patient underwent elective neck dissection or radiation. Median follow-up was 72 months.
RESULTS: Local relapse-free survival was significantly better for patients who received postoperative RT compared with those who had surgery alone: 100% vs. 29% at 5 years, respectively (p = 0.005). Five-year disease-free survival was 87.5% in the RT group vs. 31% in the surgery-alone group (p = 0.05). Regional failure was observed in 7 patients (27%), 6 with Kadish Stage B and 1 with Stage C disease. The most common site of nodal failure was Level II, and 3 patients failed in the contralateral neck. Only 3 patients with regional failure were successfully salvaged.
CONCLUSION: The high rate of regional failures when the neck is not electively treated justifies elective nodal RT in patients with both Kadish Stages B and C. In addition, our experience confirms the beneficial effect on local control of adjuvant RT to the tumor bed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21676553     DOI: 10.1016/j.ijrobp.2011.03.036

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

1.  Dural Invasion Predicts the Laterality and Development of Neck Metastases in Esthesioneuroblastoma.

Authors:  John P Marinelli; Jeffrey R Janus; Jamie J Van Gompel; Michael J Link; Eric J Moore; Kathryn M Van Abel; Brandon W Peck; Christine M Lohse; Daniel L Price
Journal:  J Neurol Surg B Skull Base       Date:  2018-02-22

2.  Risk of Delayed Lymph Node Metastasis in Clinically N0 Esthesioneuroblastoma.

Authors:  Justin G Peacock; William S Harmsen; Michael J Link; Jamie J Van Gompel; Caterina Giannini; Kerry D Olsen; Yolanda I Garces; Michelle A Neben Wittich; Daniel J Ma; Sean S Park; Robert L Foote
Journal:  J Neurol Surg B Skull Base       Date:  2016-07-06

Review 3.  Olfactory Neuroblastoma.

Authors:  Ahmed S Abdelmeguid
Journal:  Curr Oncol Rep       Date:  2018-02-07       Impact factor: 5.075

4.  Olfactory neuroblastoma: A case report.

Authors:  Gonca Hanedan Uslu; Emine Canyilmaz; Ahmet Yasar Zengin; Sevdegul Mungan; Adnan Yoney; Osman Bahadir; Huseyin Gocmez
Journal:  Oncol Lett       Date:  2015-10-20       Impact factor: 2.967

5.  Patterns of regional and distant metastasis in esthesioneuroblastoma.

Authors:  Victoria E Banuchi; Laura Dooley; Nancy Y Lee; David G Pfister; Sean McBride; Nadeem Riaz; Mark H Bilsky; Ian Ganly; Jatin P Shah; Dennis H Kraus; Luc G T Morris
Journal:  Laryngoscope       Date:  2016-02-10       Impact factor: 3.325

6.  The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck.

Authors:  Wen Jiang; Abdallah S R Mohamed; Clifton David Fuller; Betty Y S Kim; Chad Tang; G Brandon Gunn; Ehab Y Hanna; Steven J Frank; Shirley Y Su; Eduardo Diaz; Michael E Kupferman; Beth M Beadle; William H Morrison; Heath Skinner; Stephen Y Lai; Adel K El-Naggar; Franco DeMonte; David I Rosenthal; Adam S Garden; Jack Phan
Journal:  Pract Radiat Oncol       Date:  2015-11-10

7.  Changing Trends in the Management of Esthesioneuroblastoma: Irish and International Perspectives.

Authors:  Robbie S R Woods; Thavakumar Subramaniam; Mary Leader; Rory McConn-Walsh; James Paul O'Neill; Peter D Lacy
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-01

Review 8.  Radiation therapy strategies for skull-base malignancies.

Authors:  J D Palmer; M E Gamez; K Ranta; H Ruiz-Garcia; J L Peterson; D M Blakaj; D Prevedello; R Carrau; A Mahajan; K L Chaichana; D M Trifiletti
Journal:  J Neurooncol       Date:  2020-08-12       Impact factor: 4.130

9.  Nodal metastasis and elective nodal level treatment in sinonasal small-cell and sinonasal undifferentiated carcinoma: a surveillance, epidemiology and end results analysis.

Authors:  Peter H Ahn; Nandita Mitra; Michelle Alonso-Basanta; Nithin D Adappa; James N Palmer; Bert W O'Malley; Christopher H Rassekh; Ara Chalian; Roger B Cohen; Alexander Lin
Journal:  Br J Radiol       Date:  2015-11-11       Impact factor: 3.039

10.  Patterns of failures after surgical resection in olfactory neuroblastoma.

Authors:  Nalee Kim; Chang Geol Lee; Eui Hyun Kim; Chang-Hoon Kim; Ki Chang Keum; Kyu-Sung Lee; Jong Hee Chang; Chang-Ok Suh
Journal:  J Neurooncol       Date:  2018-11-30       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.